CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Singulex Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Singulex Inc
1701 Harbor Bay Pkwy Ste 200
Phone: (510) 995-9000p:510 995-9000 ALAMEDA, CA  94502-3014  United States Fax: (510) 995-9092f:510 995-9092
Business Summary
Singulex, Inc. is a commercial stage, next Generation Immunodiagnostics (NGI) company. The Company's single Molecule Counting (SMC) technology is a part of NGI, and provides ultra-sensitivity in the precision measurement of biomarkers. Powered by SMC technology, Singulex NGI commercial offerings are transforming patient care from reactive disease treatment to proactive health management. Singulex delivers SMC technology through its clinical lab. SMC technology can be applied to existing and newly identified biomarkers to aid physician decision making in cardiovascular, oncology, infectious disease, inflammation/immunology, and CNS applications. Its technology couples digital SMC technology with microparticle-based immunoassays to provide sensitivity and dynamic range. A biological sample (such as blood plasma) containing the analyte of interest is combined with paramagnetic micro-particles coated with capture antibodies and detection antibodies labeled with fluorescent dye.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-YesYesYes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/201212/31/2011YesYes--Yes

Industries
SIC Code Description
2835 In vitro and in vivo diagnostic substances
8071 Medical laboratories

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
President, Chief Executive Officer GuidoBaechler 5/1/2013 1/1/2008
Chief Financial Officer MichaelBell 50 5/1/2012 5/1/2012
Senior Vice President - Sales and Marketing and Chief Commercial Officer Frederick S.Feinberg 10/1/2011 10/1/2011
6 additional Officers and Directors records available in full report.

General Information
Number of Employees: 177 (As of 6/30/2012)
Outstanding Shares: 590,107 (As of 6/30/2012)
Shareholders: 56
Stock Exchange: AMEX
Federal Tax Id: 134213664
Fax Number: (510) 995-9092
Email Address: info@singulex.com


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, July 23, 2023